Insider TradingJul 13, 2026, 11:32 AM
GSK PDMRs Acquire Shares Under Share Reward Plan & Dividend Reinvestment
AI Summary
GSK plc announced that several Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) acquired ordinary shares on July 9, 2026. These acquisitions were made under the company's Share Reward Plan, including both partnership and matching shares, and through the re-investment of dividends. The transactions took place on the London Stock Exchange at prices around £19.6290 per share.
Key Highlights
- Multiple GSK PDMRs and PCAs acquired ordinary shares on July 9, 2026.
- Transactions occurred on the London Stock Exchange at prices around £19.6290 per share.
- Julie Brown (CFO) acquired 12 shares under the Share Reward Plan.
- James Ford (SVP & Group General Counsel) acquired 12 shares under the Share Reward Plan and 11 shares via dividend re-investment.
- Victoria Whyte (SVP & Company Secretary) acquired 14 shares under the Share Reward Plan and 216 shares via dividend re-investment.
- Iain Whyte (PCA of Victoria Whyte) acquired 1,050 shares via dividend re-investment.
- Lynn Baxter (President, Europe) acquired 34 shares via dividend re-investment.
- Neil Falkingham (PCA of Lynn Baxter) acquired 12 shares under the Share Reward Plan and 57 shares via dividend re-investment.
Price Impact
More from GSK